Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

UK scientists to examine swine flu

April 29, 2009 Research and Development h1n1

UK scientists will examine new samples of swine influenza as part of the global race to develop a vaccine against …
News

GSK pledges help in flu outbreak

April 28, 2009 Research and Development GSK, h1n1

GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …
News

Pfizer taps UCL for stem cell expertise

April 28, 2009 Research and Development Pfizer, UCL, ophthalmology, regenerative medicine

 Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …
News

AZ’s Iressa to make comeback

April 28, 2009 Research and Development, Sales and Marketing AZ, Iressa

AstraZeneca's Iressa is set to make a comeback after a European committee recommended its use for a sub-group of lung …
News

GSK and Pfizer joint venture more than a defensive move

April 27, 2009 Research and Development, Sales and Marketing GSK, Pfizer

GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
News

Strong prospects for Novartis cancer drug, say analysts

April 24, 2009 Research and Development, Sales and Marketing Afinitor, Novartis

The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …
News

Sanofi-Aventis commits 100 million euros to Chinese expansion

April 23, 2009 Research and Development Asia, China, Sanofi-Aventis

France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …
News

NICE approves Bayer’s Xarelto

April 23, 2009 Research and Development Bayer, NICE, Xarelto

NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …
News

Pharma-NHS joint working

April 22, 2009 Research and Development, Sales and Marketing ABPI, doctors, industry relations

An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …
Feature

Little benefit to pharma from G20 initiatives

April 22, 2009 Research and Development, Sales and Marketing Datamonitor, strategy

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …
News

AZ shuns mega-mergers but still open to smaller deals

April 21, 2009 Research and Development, Sales and Marketing AZ

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …
News

Pfizer opens $200m R&D site in St Louis

April 21, 2009 Research and Development Pfizer, US

News

Is the UK falling behind in clinical trials?

April 21, 2009 Research and Development NHS

New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …
News

GSK buys Stiefel for $3.6bn

April 20, 2009 Research and Development, Sales and Marketing GSK, MA

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
News

GSK and Pfizer to create HIV joint venture company

April 16, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026